(Q45722362)
Statements
1 reference
Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer (English)
1 reference
1 reference
Christoph Rochlitz
1 reference
Robert Figlin
1 reference
Patrick Squiban
1 reference
Marc Salzberg
1 reference
Miklos Pless
1 reference
Richard Herrmann
1 reference
Yongxiang Zhao
1 reference
Nadine Bizouarne
1 reference
Martine Baudin
1 reference
Bruce Acres
1 reference
1 August 2003
1 reference
1 reference
Identifiers
1 reference